US Patent Issued to Dana-Farber Cancer Institute on Sept. 9 for "Potent and selective azaindole inhibitors of CDK8 and CDK19" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 10 -- United States Patent no. 12,410,194, issued on Sept. 9, was assigned to Dana-Farber Cancer Institute Inc. (Boston).

"Potent and selective azaindole inhibitors of CDK8 and CDK19" was invented by Nathanael S. Gray (Jamaica Plain, Mass.), John M. Hatcher (Boston) and Prasanna Sreevatsan (Watertown, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with CDK8 and/or CDK19."

The patent was filed on Nov. 25, 2020, under Application No. 17/756,413.

*For further information, including images, charts and tables, please visi...